| Old Articles: <Older 33441-33450 Newer> |
|---|
 |
The Motley Fool
December 10, 2008
Rich Duprey |
Detroit's Dance With the Devil The bailout of the auto industry has ridden some rough road lately, and although a vote is possible in the House today, it's the nuts and bolts that may end up proving its undoing.   |
The Motley Fool
December 10, 2008
Brian Orelli |
A Painless Advisory Panel Meeting Genzyme might be getting a Christmas present from the Food and Drug Administration. An FDA advisory panel unanimously recommended approval for Genzyme's osteoarthritis pain drug Synvisc-One. |
The Motley Fool
December 10, 2008
Rick Aristotle Munarriz |
Is it Time for Mel Karmazin to Go? Killing off many niche music channels, and replacing them with somewhat similar content, may have been a shrewd cost-shaving move. But is it coming at a price for Sirius XM? |
The Motley Fool
December 10, 2008
Tim Beyers |
Stocks the Rich Executives Are Buying Insider buying: Akamai Technologies... Global Industries... TBS International... Visa... Walter Industries... |
The Motley Fool
December 10, 2008
Morgan Housel |
5 Stocks to Avoid in 2009 There's value in today's market, but you won't find it in these five stocks. Read on to see which stocks to avoid right now. |
The Motley Fool
December 10, 2008
Rick Aristotle Munarriz |
Blockbuster CEO Has Answers An interview with Jim Keyes shows his confidence in Blockbuster's future. |
The Motley Fool
December 10, 2008 |
2 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: UltraShort FTSE/Xinhua China 25 ProShares... Campbell Soup Company... |
The Motley Fool
December 10, 2008
Rick Aristotle Munarriz |
You Can't Spell "Weak" Without EA The video game software giant is slashing its revenue and earnings projections for fiscal 2009. |
The Motley Fool
December 10, 2008
Brian Orelli |
Merck: Same Plan, With a Twist With increasing generic competition and languishing sales of cholesterol-lowering drugs Vytorin and Zetia, Merck is doing its best to replace sales by pushing new drugs through its pipeline. |
The Motley Fool
December 10, 2008
Chris Jones |
It's a Small UTi Worldwide After All Since economies everywhere are facing hard times and shipping volumes have dropped as a result, now UTi is shrinking its costs in order to carry on. |
| <Older 33441-33450 Newer> Return to current articles. |
